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Aims and method We assessed venous thromboembolism (VTE) risk, barriers to
prescribing VTE prophylaxis and completion of VTE risk assessment in psychiatric in-
patients. This was a cross-sectional study conducted across three centres. We used
the UK Department of Health VTE risk assessment tool which had been adapted for
psychiatric patients.
Results Of the 470 patients assessed, 144 (30.6%) were at increased risk of VTE.
Patients on old age wards were more likely to be at increased risk than those on
general adult wards (odds ratio = 2.26, 95% CI 1.51–3.37). Of those at higher risk of
VTE, auditors recorded concerns about prescribing prophylaxis in 70 patients
(14.9%). Only 20 (4.3%) patients had a completed risk assessment.
Clinical implications Mental health in-patients are likely to be at increased risk of
VTE. VTE risk assessment is not currently embedded in psychiatric in-patient care.
There is a need for guidance speciﬁc to this population.
Declaration of interest None.
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Venous thromboembolism (VTE) is a potentially fatal con-
dition. Hospital-associated VTE leads to more than 25 000
deaths per year in the UK.1 VTE-related morbidity has sig-
niﬁcant eﬀects on quality of life and healthcare costs.2
Extensive research has allowed the development of guide-
lines for diagnosis and management of VTE risk in hospi-
tals.3 However, there is a paucity of evidence regarding
VTE risk in psychiatric in-patients. In March 2018, the
National Institute for Health and Care and Excellence
(NICE) released updated guidelines for VTE.4 They
included a new recommendation that all mental health
in-patients should have a VTE risk assessment on
admission.
VTE has an incidence of between 2 and 12% among
psychiatric in-patients.5,6 While psychiatric in-patients are
often more mobile than those in acute hospital wards,
there is evidence of psychiatry-speciﬁc risk factors. Case
reports have linked VTE with both antipsychotic drugs7–10
and physical restraint.11–14 Antipsychotics can increase risk
of VTE 3–4-fold.7 Prospective cohort studies have found
that patients who had been physically restrained were
more likely to develop VTE.5 Patients with a diagnosis of
dementia are also likely to develop VTE.6 Additionally,
many psychiatric in-patients are aged over 60 years or
have comorbidities which increase their risk of VTE.15–17
This cross-sectional, multicentre study aimed to assess
VTE risk in psychiatric in-patients. We hypothesised that:
(a) a signiﬁcant proportion of psychiatric patients are at
risk of VTE, and (b) VTE risk is not routinely assessed in
this group.
Method
Sample
Patient records were sampled from 27 psychiatric in-patient
wards across three sites: Cardiﬀ and Vale University Health
Board, South London and the Maudsley NHS Foundation
Trust, and NHS Lothian. The project was registered with
the audit departments of each National Health Service
(NHS) trust. As the project was under an audit framework,
ethical approval was not required. Ten wards were included
in Cardiﬀ, nine in London and eight in Edinburgh.
Addictions units and child and adolescent mental health ser-
vices (CAMHS) wards were excluded.
Data collection
Data were collected across the three sites by teams of med-
ical students from Cardiﬀ University, King’s College London
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and the University of Edinburgh. Before commencing data
collection, all students completed an online national training
module on VTE assessment,18 ensuring they were knowl-
edgeable about VTE risk and prophylactic management.
The students were supervised locally by psychiatric trainees,
as part of a larger nationwide student audit scheme, Student
Psychiatry Audit and Research Collaborative.19
We used the UK Department of Health VTE risk assess-
ment tool (available at https://www.nice.org.uk/guidance/
ng89/resources/department-of-health-vte-risk-assessment-
tool-pdf-4787149213), which had been adapted to include
VTE risk factors thought to be speciﬁc for psychiatric
patients (Table 1). These adaptations were based on the ﬁnd-
ings from a quality improvement programme conducted in
South London and Maudsley NHS Foundation Trust in
which semi-structured interviews were conducted with
mental health staﬀ. Information was gathered from elec-
tronic patient records and drug charts, with any discrepan-
cies clariﬁed with ward staﬀ. A standardised electronic
form was used to record data on the Welsh Digital Data
Collection Platform.20 The assessors recorded whether
each patient was at an increased risk of VTE based on the
proforma and their clinical knowledge of VTE. They also
noted whether the clinical team had recorded any perceived
contraindications or other barriers to prescribing antithrom-
botic stockings or anticoagulants for the patient, and
whether the patient had a completed VTE risk assessment
form. The data were collected on 5–7 July 2016 in Cardiﬀ,
12–19 December in London and 7–31 March 2017 in
Edinburgh.
Statistical methods and data analysis
We used SPSS to conduct our data analysis. We calculated
descriptive statistics for patient characteristics, risk assess-
ment completion, patient VTE risk and documented reasons
for not prescribing VTE prophylaxis. We conducted χ2 tests
of independence to test for a diﬀerence between (a) VTE risk
between the types of ward, (b) VTE risk between the diﬀer-
ent sites, (c) VTE risk assessment completion between the
diﬀerent sites, and (d) recorded concerns about prescribing
VTE prophylaxis between the diﬀerent sites.
Ethics statement
This study came under the audit framework and so did not
require formal ethical approval. The project was registered
with the local audit department at each site and permission
was granted.
Results
Patient characteristics
In total, the sample comprised 470 acute adult and old age
psychiatric in-patients on 27 wards across the three sites:
195 patients in London, 130 in Edinburgh and 145 in
Cardiﬀ. Of these patients, 202 (43.0%) were over 60 years
old. Table 2 outlines the percentage of patients with each
primary diagnosis. A total of 365 (77.7%) patients were pre-
scribed at least one antipsychotic medication, and eight
(1.7%) patients had been physically restrained on that
admission.
VTE risk
We found 144 (30.6%) of in-patients to be at an increased
risk of VTE. Patients on old age wards were more likely to
be at increased risk of VTE (41.4%) than patients on general
adult wards (Table 3). In our sample, 96 (20.4%) patients
had a diagnosis of dementia and 37 (39%) of these were
found to be at an increased risk of VTE. The number of
patients at an increased risk of VTE did not diﬀer signiﬁ-
cantly between sites (P = 0.055).
Risk assessment and contraindications
Of the 470 patients included, only 20 (4.3%) had a VTE risk
assessment completed by the clinical team. There were
Table 1 Adapted Department of Health VTE risk assessment
Thrombosis risk Bleeding risk
Patient
characteristics
Presence of active
cancer
Bleeding disorder Psychiatric diagnosis
Age >60 years Anticoagulated Age
Dehydration Previous stroke Ethnicity
Thrombophilias Thrombocytopenia Antipsychotic use
Obesity Hypertension Physical restraint
Pregnancy Recent neurosurgery Thromboprophylaxis
Reduced mobility Recent spinal
procedures
Legal restrictions
Recent knee/hip
replacement
Recent hip fracture
Recent surgical
procedure
Table 2 Patients by diagnosis
Diagnosis ICD-10 codes
Number of
patients (%)
Functional psychosis F20, F29, F23.2,
F20.9
193 (41.1)
Bipolar aﬀective disorder F31 61 (13.0)
Depression/anxiety F06.3, F06.4, F41,
F41.0, F41.1, F41.2,
38 (8.1)
Neurodevelopmental
disorder
F83, F84 4 (0.9)
Dementia F00, F01, F02, F02.3,
F03
98 (20.9)
Other organic disorder F07.8, F07.9, F09 11 (2.3)
Drugs/alcohol F10, F11, F12, F13, F14,
F15, F16, F19, Z71.4
13 (2.8)
Other aﬀective F34.8, F38, F39 3 (0.6)
Personality disorder F07.0, F60, F60.9 11 (2.3)
Other F06.9, F99, Z71.1 38 (8.1)
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signiﬁcant diﬀerences among the sites in the proportion of
patients who had a completed risk assessment form
(Cardiﬀ = 1.4%, London = 8.7%, Edinburgh = 0.8%, P < 0.001).
There were potential contraindications or concerns
about prescribing VTE prophylaxis in 14.9% of all patients
and 20.8% of those patients considered to be at increased
VTE risk. Table 4 shows the perceived barriers to prophy-
laxis. There were signiﬁcant diﬀerences among the three
sites in the proportion of patients for whom there were con-
cerns about prescribing VTE prophylaxis (Cardiﬀ = 31%,
London = 6%, Edinburgh = 10%, P < 0.001).
Discussion
The primary aim of this study was to assess whether psychi-
atric in-patients are at increased risk of VTE. Nearly a third
of patients were judged to be at increased risk, indicating
that they would merit some form of intervention on an
acute medical ward, such as increasing patient mobility,
compression stockings or sub-cutaneous heparin. Our
results support those of Choudry and Job,21 who audited
VTE risk assessment on old-age psychiatric wards. They
found that all patients assessed during the 2 week audit
period had at least one risk factor for VTE, and nearly
two-thirds of patients (63%) had at least three. None of
the patients audited had received a risk assessment. Our
ﬁndings are also supported by a large study in France, in
which 458 psychiatric in-patients were followed for 90
days,6 and a study conducted in Japan (N = 190) where dop-
pler ultrasound scanning was used to ensure that even
asymptomatic VTE was recorded.5 Both of these studies
found a high incidence of VTE among psychiatric in-
patients. However, these studies did not record how many
of these patients had received a risk assessment from ward
staﬀ before each study had started.
In our sample, the majority of patients were prescribed
at least one antipsychotic medication. There is evidence to
suggest a link between these drugs and VTE risk. Lacut
and colleagues used a case–control study (N = 677) to exam-
ine the relationship between use of antipsychotic drugs and
VTE.7 They demonstrated a 3.5-fold increased risk of VTE
in patients exposed to antipsychotic agents, particularly phe-
nothiazines, butyrophenones and benzamides. A strong asso-
ciation has been identiﬁed between chlorpromazine use and
VTE, based on a cross-sectional study of more than 29 000
individuals who received antipsychotic drugs.22 The risk
was greatest during the early stages of treatment. Clozapine
has also been implicated in VTE risk, as it has been asso-
ciated with a fatal pulmonary embolus rate of more than
27 times that seen in the general population.8,9 Comparison
of such studies with those which have quantiﬁed risk for
well-established VTE risk factors emphasise the importance
of addressing psychiatric risk factors to reduce VTE inci-
dence. For example, risk of VTE for women taking the com-
bined contraceptive pill is almost three times that of
non-exposed women,23 and the presence of malignant neo-
plasm has an odds ratio of 4.1 for VTE compared with
those without cancer.24
In the current study, only a small minority of patients
were exposed to frequent physical restraint. However, this
factor should still be given consideration. Case reports
have suggested that use of physical restraint is another psy-
chiatric in-patient factor which may inﬂuence VTE risk.12
A signiﬁcant association between physical restraint and the
development of VTE has been demonstrated in patients
with psychiatric illnesses.25 One study highlighted the eﬀect-
iveness of prophylactic heparin in 170 patients with schizo-
phrenia, 82% of whom underwent at least one episode of
physical restraint.26 This was a large study (N = 679),
although it had a retrospective design and all in-patients
were from the same location, which reduces the generalis-
ability of the results. VTE has also been shown to occur in
physically restrained psychiatric patients despite pharmaco-
logical prophylaxis, suggesting that a thorough VTE assess-
ment and multi-modal prophylaxis may be required in
these patients.5 Mechanisms thought to be related to this
association include stasis-induced vein wall injury and exag-
gerated endothelial tissue factor expression.25
We found that patients on old age psychiatric wards
were at signiﬁcantly greater risk of thromboembolism than
those on general adult wards. The diﬀerence in the risk pro-
ﬁle of these groups is not surprising given the overlap
between thromboembolism risk and general ageing, includ-
ing reduced mobility, as well as other speciﬁc comorbidities
such as malignancy.27 In our study, almost 40% of those with
Table 4 Perceived barriers to prescribing VTE prophylaxis
Reason for concern Number of patients (%)
Active self-harm 2 (0.43)
High risk of self-harm/previous self-harm 19 (4.04)
Self-neglect 25 (5.32)
Physical health risk 5 (1.06)
Medication 3 (0.64)
Alcohol use 1 (0.21)
Fall risk 6 (1.28)
‘Risk may outweigh beneﬁts’ 4 (0.85)
Multiple reasons stated 5 (1.06)
Table 3 VTE risk
Patient
characteristics
Number
of patients
(% of total)
Patients at
risk of VTE
according to
tool (%)
P for
independence
(χ2)
All 470 144 (30.6)
In-patients on
old age wards
181 (38.5) 75 (41.4) <0.001
In-patients on
general adult
wards
289 (61.5) 69 (23.9)
Patients with
dementia
diagnosis
96 (20.4) 37 (39)
Site: Cardiﬀ 145 (30.9) 56 (38.6) 0.055
Site: Edinburgh 130 (27.7) 37 (28.5)
Site: London 195 (41.5) 51 (26.2)
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dementia were at increased risk. Dementia may lead to VTE
as it is associated with reduced mobility, frailty and dehydra-
tion.28 Moreover, impaired communication may delay diag-
nosis of VTE.
In addition to the medical contraindications to mechan-
ical or pharmacological VTE prophylaxis, there may be other
barriers to prescribing in mental health settings. Nearly a
third (27%) of patients in our study were recorded as
being at high risk of self-harm. Clinicians may be wary of
prescribing compression stockings as they could be used as
ligatures29 and anti-coagulant medications may increase
bleeding in individuals who self-harm by cutting.
A minority of patients had a structured VTE risk assess-
ment completed (4.3%) even when risk assessment profor-
mas were readily available. In one centre, the VTE risk
assessment proforma was incorporated into all drug charts.
The low rates of proforma completion suggest that staﬀ are
not aware of the need to measure VTE risk. A higher propor-
tion of patients at the London site had a VTE risk assessment
than those in Cardiﬀ or Edinburgh. A local audit of VTE risk
had been completed at the London site previously, which
may have resulted in greater awareness among staﬀ. In
March 2018, NICE released updated guidelines for VTE.4
They included a new recommendation that all mental health
in-patients should have a VTE risk assessment on admission.
This study has several strengths. We studied a large
sample from multiple centres and used a standardised
assessment tool. The results should therefore be generalis-
able to other in-patient psychiatric populations. There are
also some limitations. Some in-patient groups were not
included, such as CAMHS and addictions units. The VTE
risk assessment tool, while recommended by NICE, has
not been formally validated in this population. However,
we adapted it to include factors relevant to mental health.
Assessors were required to judge whether each patient was
at an increased risk of VTE based on the information col-
lected. However, they had all undertaken additional training
on VTE risk assessment and management, and were super-
vised by a doctor in psychiatry training. It would have
been useful to compare the VTE risk in our patient popula-
tion with that of general medical or surgical patients.
However, audit registration in acute trusts without mental
health provision was not feasible. We were unable to ascer-
tain whether those identiﬁed as being at an increased risk of
VTE went on to develop the condition.
Overall, our ﬁndings suggest that psychiatric in-patients
are likely to be at increased risk of VTE. Older adults are
most likely to be at risk. Further research is required to
assess the risk posed by antipsychotics and physical
restraint. Speciﬁc guidelines for VTE risk management in
psychiatric patients and greater staﬀ awareness of VTE
risk are required.
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